-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Cogent Biosciences Announces Detailed Clinical Data From Peak Phase 3 Trial With Bezuclastinib In Combination With Sunitinib

Reuters·05/30/2026 12:03:25

Please log in to view news